We specialize in formulation development of injectable peptides and proteins tailored for first human use.
Discovery and development of novel antibiotics to treat multidrug-resistant infections.
Specialized in fusion molecules based on secondary metabolites from eukaryotes.
Developing game-changing alternatives to fossil-based plastics
Develops enzyme-powered topical products for improved management of skin conditions
Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis